Literature DB >> 7853273

Hormonal factors in vulvar cancer. A case-control study.

K J Sherman1, J R Daling, B McKnight, J Chu.   

Abstract

As part of a case-control study of vulvar cancer, we examined the role of reproductive history, menstrual history, exogenous estrogen use and body mass in the etiology of this disease. A total of 330 women with vulvar squamous cell cancer (259 in situ, 81 invasive), aged 18-79 years, who were diagnosed with this tumor during 1980-1990 were interviewed. Their responses were compared to those of 1,010 women who were selected from the general population by means of random digit dialing. Cases and controls did not differ regarding age at menopause, parity, number of prior pregnancies or number of prior births, history of miscarriage or use of noncontraceptive estrogens. Women diagnosed with vulvar cancer were slightly more likely to have experienced menarche at < 12 years (odds ratio [OR] = 1.8, 95% confidence interval [CI] = 1.2-2.7, in situ cancer; OR = 1.6, 95% CI = 0.8-3.1, invasive cancer), to have excess weight (invasive cancer only, OR = 2.9, 95% CI = 1.5-5.8 for highest tertile of Quetelet's index) and, among gravid women, to have had their first pregnancy after age 24 (in situ cancer only, OR = 1.5, 95% CI = 0.9-2.5). These data, together with similar results from previous studies and quantitative studies of hormone receptors in vulvar tissue, suggest that in situ and invasive vulvar cancer are not strongly hormone dependent tumors.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7853273

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  6 in total

1.  Epidemiology of vulvar neoplasia in the NIH-AARP Study.

Authors:  Louise A Brinton; Jake E Thistle; Linda M Liao; Britton Trabert
Journal:  Gynecol Oncol       Date:  2017-02-22       Impact factor: 5.482

2.  Hormone Replacement Therapy After Gynaecological Malignancies: a Review Article.

Authors:  Marina Sourouni; Ludwig Kiesel
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-05-20       Impact factor: 2.915

Review 3.  Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.

Authors:  Tamás Deli; Mónika Orosz; Attila Jakab
Journal:  Pathol Oncol Res       Date:  2019-01-08       Impact factor: 3.201

Review 4.  Hormonal Therapy for Gynecological Cancers: How Far Has Science Progressed toward Clinical Applications?

Authors:  Saikat Mitra; Mashia Subha Lami; Avoy Ghosh; Rajib Das; Trina Ekawati Tallei; Fahadul Islam; Kuldeep Dhama; M Yasmin Begum; Afaf Aldahish; Kumarappan Chidambaram; Talha Bin Emran
Journal:  Cancers (Basel)       Date:  2022-02-01       Impact factor: 6.639

5.  Fertility-sparing treatment of locally advanced vulvar squamous cell carcinoma in a young patient.

Authors:  Nujsaubnusi C Vue; Nicole B Gaulin; Zachary D Horne; Sharon Liang; Thomas C Krivak
Journal:  Gynecol Oncol Rep       Date:  2022-09-13

Review 6.  New Insights into the Epidemiology of Vulvar Cancer: Systematic Literature Review for an Update of Incidence and Risk Factors.

Authors:  Lauro Bucchi; Margherita Pizzato; Stefano Rosso; Stefano Ferretti
Journal:  Cancers (Basel)       Date:  2022-01-13       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.